يعرض 1 - 10 نتائج من 29 نتيجة بحث عن '"Bober, MB"', وقت الاستعلام: 1.15s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    العلاقة: pii: 10.1177_1759720X221084848; Savarirayan, R., De Bergua, J. M., Arundel, P., McDevitt, H., Cormier-Daire, V., Saraff, V., Skae, M., Delgado, B., Leiva-Gea, A., Santos-Simarro, F., Salles, J. P., Nicolino, M., Rossi, M., Kannu, P., Bober, M. B., Phillips, J., Saal, H., Harmatz, P., Burren, C. ,. Irving, M. (2022). Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 14, https://doi.org/10.1177/1759720X221084848Test.; http://hdl.handle.net/11343/307122Test

  5. 5
    دورية أكاديمية

    العلاقة: pii: S1098-3600(22)00906-6; Savarirayan, R., Irving, M., Harmatz, P., Delgado, B., Wilcox, W. R., Philips, J., Owen, N., Bacino, C. A., Tofts, L., Charrow, J., Polgreen, L. E., Hoover-Fong, J., Arundel, P., Ginebreda, I., Saal, H. M., Basel, D., Font, R. U., Ozono, K., Bober, M. B. ,. Day, J. (2022). Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study. Genet Med, 24 (12), pp.2444-2452. https://doi.org/10.1016/j.gim.2022.08.015Test.; http://hdl.handle.net/11343/322234Test

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية

    العلاقة: Savarirayan, R., Tofts, L., Irving, M., Wilcox, W., Bacino, C. A., Hoover-Fong, J., Font, R. U., Harmatz, P., Rutsch, F., Bober, M. B., Polgreen, L., Ginebreda, I., Mohnike, K., Charrow, J., Hoernschemeyer, D., Ozono, K., Alanay, Y., Arundel, P., Kagami, S. ,. Day, J. (2021). Persistent and Stable Growth Promoting Effects of Vosoritide in Children With Achondroplasia for up to 2 Years: Results From the Ongoing Phase 3 Extension Study. Journal of the Endocrine Society, 5 (Supplement_1), pp.A670-A671. https://doi.org/10.1210/jendso/bvab048.1368Test.; http://hdl.handle.net/11343/301598Test

  9. 9
    دورية أكاديمية

    العلاقة: pii: S1098-3600(21)05439-3; Savarirayan, R., Tofts, L., Irving, M., Wilcox, W. R., Bacino, C. A., Hoover-Fong, J., Font, R. U., Harmatz, P., Rutsch, F., Bober, M. B., Polgreen, L. E., Ginebreda, I., Mohnike, K., Charrow, J., Hoernschemeyer, D., Ozono, K., Alanay, Y., Arundel, P., Kotani, Y. ,. Day, J. R. S. (2021). Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study. GENETICS IN MEDICINE, 23 (12), pp.2443-2447. https://doi.org/10.1038/s41436-021-01287-7Test.; http://hdl.handle.net/11343/287664Test

  10. 10
    دورية أكاديمية

    العلاقة: pii: 10.1186/s13023-021-01678-8; Savarirayan, R., Tunkel, D. E., Sterni, L. M., Bober, M. B., Cho, T. -J., Goldberg, M. J., Hoover-Fong, J., Irving, M., Kamps, S. E., Mackenzie, W. G., Raggio, C., Spencer, S. A., Bompadre, V. & White, K. K. (2021). Best practice guidelines in managing the craniofacial aspects of skeletal dysplasia. ORPHANET JOURNAL OF RARE DISEASES, 16 (1), https://doi.org/10.1186/s13023-021-01678-8Test.; http://hdl.handle.net/11343/272597Test